These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 1347424

  • 1. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML.
    Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
    [Abstract] [Full Text] [Related]

  • 2. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G, Pozza F, Meli S, Reitano M, Santini G, Bevilacqua P.
    Anticancer Res; 1991 Feb; 11(6):2015-21. PubMed ID: 1776834
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2002 Feb; 22(1A):295-8. PubMed ID: 12017306
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O, Sullivan S, Sun XF, Wingren S, Nordenskjöld B.
    Cytometry; 1994 Jun 01; 16(2):160-8. PubMed ID: 7924685
    [Abstract] [Full Text] [Related]

  • 6. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S, Bui MM, Lu L.
    Ann Clin Lab Sci; 1998 Jun 01; 28(6):315-23. PubMed ID: 9846198
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
    Lee AK, Dugan J, Hamilton WM, Cook L, Heatley G, Kamat B, Silverman ML.
    Mod Pathol; 1991 Mar 01; 4(2):178-82. PubMed ID: 2047381
    [Abstract] [Full Text] [Related]

  • 9. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
    Lee AK, Wiley B, Dugan JM, Hamilton WH, Loda M, Heatley GJ, Cook L, Silverman ML.
    Pathol Res Pract; 1992 Jun 01; 188(4-5):428-32. PubMed ID: 1329051
    [Abstract] [Full Text] [Related]

  • 10. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS, Bacus JW, Slamon DJ, Press MF.
    Arch Pathol Lab Med; 1990 Feb 01; 114(2):164-9. PubMed ID: 1967930
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP, Hoop JG, Nap M.
    Anticancer Res; 2003 Feb 01; 23(2A):999-1006. PubMed ID: 12820338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI, Glukhova EI, Zhukova LG, Ermilova VD, Bogatyrev VN, Baryshnikov AIu.
    Arkh Patol; 2003 Feb 01; 65(5):25-9. PubMed ID: 14664144
    [Abstract] [Full Text] [Related]

  • 15. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL, Luo I, Mikhail N, Rasková J, Raska K.
    Cytometry; 1995 Sep 15; 22(3):181-9. PubMed ID: 8556949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
    Martinez-Arribas F, Nuñez-Villar MJ, Lucas AR, Sanchez J, Tejerina A, Schneider J.
    Breast Cancer Res Treat; 2005 Jul 15; 92(1):77-80. PubMed ID: 15980994
    [Abstract] [Full Text] [Related]

  • 18. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
    Dabbs DJ.
    Mod Pathol; 1995 Aug 15; 8(6):637-42. PubMed ID: 8532697
    [Abstract] [Full Text] [Related]

  • 19. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP, Steindorfer P, Wirnsberger GH, Klimpfinger M, Ratschek M, Puerstner P, Auner H, Berhold A.
    Anticancer Res; 1995 Aug 15; 15(2):581-6. PubMed ID: 7763041
    [Abstract] [Full Text] [Related]

  • 20. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Aug 15; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.